Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to $7.6 million.

  • InspireMD's Cash from Investing Activities rose 22746.46% to $7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.8 million, marking a year-over-year increase of 42296.58%. This contributed to the annual value of $12.6 million for FY2024, which is 17855.46% up from last year.
  • Latest data reveals that InspireMD reported Cash from Investing Activities of $7.6 million as of Q3 2025, which was up 22746.46% from $5.3 million recorded in Q2 2025.
  • InspireMD's 5-year Cash from Investing Activities high stood at $8.2 million for Q4 2024, and its period low was -$26.9 million during Q2 2023.
  • In the last 5 years, InspireMD's Cash from Investing Activities had a median value of $1.9 million in 2022 and averaged -$152210.5.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first plummeted by 4925510.2% in 2021, then soared by 2299444.44% in 2024.
  • InspireMD's Cash from Investing Activities (Quarter) stood at $1.8 million in 2021, then skyrocketed by 111.08% to $3.9 million in 2022, then crashed by 100.93% to -$36000.0 in 2023, then skyrocketed by 22994.44% to $8.2 million in 2024, then decreased by 8.38% to $7.6 million in 2025.
  • Its Cash from Investing Activities stands at $7.6 million for Q3 2025, versus $5.3 million for Q2 2025 and $1.7 million for Q1 2025.